BIOSPECIFICS TECHNOLOGIES CORP. Non-Employee Director Change of Control AgreementNon-Employee Director Change of Control Agreement • March 14th, 2016 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
Contract Type FiledMarch 14th, 2016 Company Industry JurisdictionThis Non-Employee Director Change of Control Agreement, effective as of April 22, 2015, is entered into by and between BioSpecifics Technologies Corp., a Delaware corporation (the “Company”), with its principal offices located at 35 Wilbur Street, Lynbrook, NY 11563, and Dr. Jyrki Mattila (the “Director”).
COLEY PHARMACEUTICAL GROUP, INC. Non-Employee Director Change of Control AgreementNon-Employee Director Change of Control Agreement • April 20th, 2005 • Coley Pharmaceutical Group, Inc. • Massachusetts
Contract Type FiledApril 20th, 2005 Company JurisdictionThis Non-Employee Director Change of Control Agreement, effective as of is entered into by and between Coley Pharmaceutical Group, Inc., a Delaware corporation (the “Company”), with its principal offices located at 20 William Street, Suite 115, Wellesley, Massachusetts 02481, and , residing at .
INTERACTIVE INTELLIGENCE, INC. NON-EMPLOYEE DIRECTOR CHANGE OF CONTROL AGREEMENTNon-Employee Director Change of Control Agreement • August 9th, 2007 • Interactive Intelligence Inc • Services-prepackaged software • Indiana
Contract Type FiledAugust 9th, 2007 Company Industry JurisdictionTHIS NON-EMPLOYEE DIRECTOR CHANGE OF CONTROL AGREEMENT (“Agreement”) is effective as of _______ __, 2007, by and between ______ (the “Director”) and Interactive Intelligence, Inc., an Indiana corporation (the “Corporation”).
INTERACTIVE INTELLIGENCE GROUP, INC. FORM OF NON-EMPLOYEE DIRECTOR CHANGE OF CONTROL AGREEMENTNon-Employee Director Change of Control Agreement • August 5th, 2016 • Interactive Intelligence Group, Inc. • Services-prepackaged software • Indiana
Contract Type FiledAugust 5th, 2016 Company Industry JurisdictionTHIS NON-EMPLOYEE DIRECTOR CHANGE OF CONTROL AGREEMENT (“Agreement”) is effective as of May 19, 2016, by and between ______ (the “Director”) and Interactive Intelligence Group, Inc., an Indiana corporation (the “Corporation”).